Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F86652036%3A_____%2F15%3A00464077" target="_blank" >RIV/86652036:_____/15:00464077 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61388971:_____/15:00464077
Výsledek na webu
<a href="http://dx.doi.org/10.1007/s13238-015-0194-9" target="_blank" >http://dx.doi.org/10.1007/s13238-015-0194-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s13238-015-0194-9" target="_blank" >10.1007/s13238-015-0194-9</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)
Popis výsledku v původním jazyce
Prostate secretory protein 94 (PSP94), a dominant protein of human seminal plasma known also as β-microseminoprotein (MSMB), has recently been shown to decrease serum level expression during prostate cancer (PC) progression and indicated as a novel promising serum oncomarker with a predictive role in PC diagnosis. In this work we aimed to generate a novel class of protein binders targeted to human PSP94 that can serve as robust capture proteins for improved PC diagnostics. We used high-complex combinatorial library derived from an albumin-binding domain (ABD) scaffold of streptococcal protein G with a theoretical complexity up to 2 x 1014 protein variants and ribosome display to generate a plasmid library of selected variants. Individual clones were characterized by binding of ABD-derived proteins to recombinant PSP94 and sequentially compared and characterized. Collection of 35 ABD-derived protein binders of human PSP94 (called PAB binders), corresponding to 29 different sequence variants, was generated. PAB036, PAB046 and PAB050 were identified as the most promising binding candidates characterized in ELISA. Their stability was verified by thermal shift assay and the binding affinity to the recombinant PSP94 was estimated by microscale thermophoresis. These PAB variants bound to PSP94-expressing human LNCaP prostate carcinoma cells and this binding was dose-dependently inhibited by recombinant PSP94. Thus, we generated a unique collection of novel proteins binders of human PSP94 that can serve as a valuable tool for human PSP94 detection and, with a further modification, as high-affinity capture proteins for the development of biosensors for more complex PC diagnostics.
Název v anglickém jazyce
Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)
Popis výsledku anglicky
Prostate secretory protein 94 (PSP94), a dominant protein of human seminal plasma known also as β-microseminoprotein (MSMB), has recently been shown to decrease serum level expression during prostate cancer (PC) progression and indicated as a novel promising serum oncomarker with a predictive role in PC diagnosis. In this work we aimed to generate a novel class of protein binders targeted to human PSP94 that can serve as robust capture proteins for improved PC diagnostics. We used high-complex combinatorial library derived from an albumin-binding domain (ABD) scaffold of streptococcal protein G with a theoretical complexity up to 2 x 1014 protein variants and ribosome display to generate a plasmid library of selected variants. Individual clones were characterized by binding of ABD-derived proteins to recombinant PSP94 and sequentially compared and characterized. Collection of 35 ABD-derived protein binders of human PSP94 (called PAB binders), corresponding to 29 different sequence variants, was generated. PAB036, PAB046 and PAB050 were identified as the most promising binding candidates characterized in ELISA. Their stability was verified by thermal shift assay and the binding affinity to the recombinant PSP94 was estimated by microscale thermophoresis. These PAB variants bound to PSP94-expressing human LNCaP prostate carcinoma cells and this binding was dose-dependently inhibited by recombinant PSP94. Thus, we generated a unique collection of novel proteins binders of human PSP94 that can serve as a valuable tool for human PSP94 detection and, with a further modification, as high-affinity capture proteins for the development of biosensors for more complex PC diagnostics.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
EB - Genetika a molekulární biologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Protein & Cell
ISSN
1674-800X
e-ISSN
—
Svazek periodika
6
Číslo periodika v rámci svazku
10
Stát vydavatele periodika
CN - Čínská lidová republika
Počet stran výsledku
6
Strana od-do
774-779
Kód UT WoS článku
000362653100010
EID výsledku v databázi Scopus
—